Modeling doxorubicin-induced-cardiotoxicity through breast cancer patient specific iPSC-derived heart organoid

Modeling doxorubicin-induced-cardiotoxicity through breast cancer patient specific iPSC-derived heart organoid

Heart organoid (HO) technology has successfully overcome the limitations of two-dimensional (2D) disease modeling and drug testing, thereby emerging as a valuable tool in drug discovery for assessing toxicity and efficacy. However, its ability to distinguish drug responses among individuals remain u...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiye Jang, Hyewon Jung, Jaekyun Jeong, Junseok Jeon, Kyungho Lee, Hye Ryoun Jang, Jeung-Whan Han, Jaecheol Lee
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Series:	Heliyon
Subjects:	Doxorubicin-induced-cardiotoxicity Induced pluripotent stem cell Heart organoid Disease modeling Predictive model
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024147457
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bioinformatics analysis of ferroptosis-related biomarkers and potential drug predictions in doxorubicin-induced cardiotoxicity
by: Jian Yu, et al.
Published: (2025-04-01)

Mitochondrial Amount Determines Doxorubicin‐Induced Cardiotoxicity in Cardiomyocytes
by: Weiyao Xiong, et al.
Published: (2025-03-01)

Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
by: Hamdi Nsairat, et al.
Published: (2025-08-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Tetrahedral Framework Nucleic Acids Inhibit Oxidative Stress and Cardiomyocyte Apoptosis in Doxorubicin-Induced Cardiotoxicity
by: Pan H, et al.
Published: (2025-07-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Cell-Permeable Microprotein from Panax Ginseng Protects Against Doxorubicin-Induced Oxidative Stress and Cardiotoxicity
by: Bamaprasad Dutta, et al.
Published: (2025-04-01)

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Metabolomic profiling and biomarker identification for early detection and therapeutic targeting of doxorubicin-induced cardiotoxicity
by: Jingjing Ding, et al.
Published: (2025-04-01)

iPSC-Derived Biological Pacemaker—From Bench to Bedside
by: Quan Duy Vo, et al.
Published: (2024-12-01)

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review
by: Shang W, et al.
Published: (2025-07-01)

Natural epigallocatechin-3-gallocarboxylate nanoformulation loaded doxorubicin to construct a novel and low cardiotoxicity chemotherapeutic drug for high-efficiency breast cancer therapy
by: Ke Wang, et al.
Published: (2024-12-01)

Generation and purification of iPSC-derived cardiomyocytes for clinical applications
by: M. Generali, et al.
Published: (2025-04-01)

The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism
by: Shuai Shi, et al.
Published: (2025-07-01)

Promising Mesenchymal Stem Cell Intervention for Relieving Cardiac Recovery against Cardiotoxic Injury Modeling with Doxorubicin: A Novel Therapeutic Approach
by: Ozgermen Deva Basak Boztok, et al.
Published: (2025-06-01)

A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required
by: Ramzey Abujarour, et al.
Published: (2024-12-01)

Combined effects of metformin and coenzyme Q10 on doxorubicin-induced cardiotoxicity in male wistar rats
by: Faraz Mahdizadeh, et al.
Published: (2025-07-01)

Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
by: Guilherme Rabelo Nasuk, et al.
Published: (2025-07-01)

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01)

Cardiotoxicity in chemotherapeutic agents
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01)

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01)

Research on Doxorubicin-Induced Cardiotoxicity Mechanism and Its Forensic Application
by: ZHANG Shuai, et al.
Published: (2025-04-01)

5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth
by: Xinning Guo, et al.
Published: (2025-09-01)

Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study
by: Noora Alyasari, et al.
Published: (2023-12-01)

Serum and plasma sphingolipids as biomarkers of chemotherapy-induced cardiotoxicity in female patients with breast cancer
by: Samia Mohammed, et al.
Published: (2025-05-01)

NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals
by: Xiao-Peng Zhao, et al.
Published: (2025-04-01)

Longitudinal Assessment of QT Apex in Tumor‐Bearing Dogs Receiving Doxorubicin Monotherapy
by: Keita Kitagawa, et al.
Published: (2025-07-01)

Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
by: Xiaowen Shi, et al.
Published: (2024-12-01)

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
by: Rubén Fernández‐Santiago, et al.
Published: (2015-10-01)

Non-Coding RNAs in the Regulation of Doxorubicin-Induced Cardiotoxicity
by: Mengyao Sun, et al.
Published: (2025-05-01)

Derivation of human-derived iPSC line from a male adolescent with first-episode of sporadic schizophrenia
by: Youhui Jiang, et al.
Published: (2025-06-01)

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis
by: Christopher W. Hoeger, et al.
Published: (2025-07-01)

Multidisciplinary strategies to reduce radiotherapy-induced cardiotoxicity in breast cancer: surgical and technological innovations
by: Kai Lu, et al.
Published: (2025-08-01)

A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications
by: Margarita Matiukhova, et al.
Published: (2025-05-01)

Generation and Characterization of a Human-Derived iPSC line from a female child with First-Episode of sporadic schizophrenia
by: Youhui Jiang, et al.
Published: (2025-08-01)

Diacylglycerol Kinase ζ Attenuates Doxorubicin‐Induced Cardiotoxicity Through p53 Degradation
by: Shingo Tachibana, et al.
Published: (2025-01-01)

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01)

CACNA1A loss-of-function affects neurogenesis in human iPSC-derived neural models
by: Ilaria Musante, et al.
Published: (2025-06-01)

iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis
by: Jingyu Zhao, et al.
Published: (2025-02-01)